Prevalence of celiac disease in China higher than expected
Celiac disease is an autoimmune disorder caused by genetically susceptible individuals consuming food and drinks made from wheat, barley or rye and therefore containing gluten. Gluten proteins can induce inflammation in the small intestine, hindering the uptake of nutrients, and can also disturb the normal functioning of other organs. In the Western world, the prevalence of celiac disease is between 0.5 and 2% of the population.
Wheat consumption is increasing rapidly in China due to urbanisation and westernization of the traditional Chinese diet but, until recently, the status of celiac disease had not been a major research subject. Wageningen UR initiated an investigation into the true status of celiac disease as a landmark reference point. It was conducted by the Chinese scientists, with help from the Dutch scientists. Three main issues were addressed by a systematic review and meta-analysis of the Chinese and international literature: the number of definite or suspected cases of the disease reported, the frequency of the major predisposing HLA genes seen in various Chinese populations, and the amount of wheat and gluten consumption, which is the major environmental factor.
The data strongly suggest that the prevalence of celiac disease is much higher in China than previously thought. The study also suggests that in the north-western regions of China, where there is the highest influx of Western (Caucasian) genes and the highest wheat consumption, celiac disease will be more frequent and have prevalences similar to those seen in Western societies. The disease prevalence is likely to rise as the Chinese adopt a more Western life style, with increased consumption of wheat and gluten-containing products. This will be true throughout the country, but especially in urban environments. These factors mean China is a country at risk of celiac disease becoming a common disease and strategies for prevention should be developed to guarantee the health of Chinese individuals.
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.